Weight loss and progression of early atherosclerosis in the carotid artery: a four-year controlled study of obese subjects.
OBJECTIVE
To investigate the extent of carotid artery atherosclerosis in obese subjects and to examine the possible effects of weight loss on atherosclerotic development.


METHODS
Controlled 4 y intervention study.


METHODS
20 obese patients treated with weight-reducing gastroplasty, 19 obese patients treated with dietary recommendations and 35 lean subjects.


METHODS
Body weight, blood pressure, blood lipids, glucose and insulin were measured. A B-mode ultrasound was recorded to determine the intima-media thickness (IMT) and lumen diameter (LD) of the carotid artery. Study groups were investigated at baseline and re-examined after 3 to 4 y of follow-up.


RESULTS
At baseline, obese patients had higher blood pressure, serum total cholesterol, triglycerides, glucose and insulin compared with lean subjects; they also had a larger IMT in the carotid artery bulb (P<0.05) and a larger LD in the common carotid artery (P<0.01). After 4 y of follow-up, obese patients treated with surgery displayed a mean weight loss of 22 kg (19%), while the average weight in the obese control group remained unchanged (P<0.001). The weight loss group showed improvements in blood pressure, HDL-cholesterol, triglycerides and insulin compared with the obese control group (P<0.05). The progression rate of carotid bulb IMT in the weight loss group was similar to that observed in the lean control group (0.024 vs 0.025 mm/y, n.s.), whereas the IMT progression rate was almost three times higher in the obese control group (0.068 mm/y, P<0.05 compared with lean controls).


CONCLUSIONS
Obese people have an unfavourable risk factor profile and signs of premature carotid artery atherosclerosis. Weight loss is followed by an improvement in several risk factors and may reduce the progression rate of atherosclerotic changes in the carotid artery bulb.
Karason
K
K
Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden. kristjan.karason@medfak.gu.se
Wikstrand
J
J
Sjöström
L
L
Wendelhag
I
I
D000328:Adult; D001161:Arteriosclerosis / Q000097:blood / Q000000981:diagnostic imaging / Q000503:physiopathology*; D001786:Blood Glucose; D001835:Body Weight; D002339:Carotid Arteries / Q000000981:diagnostic imaging / Q000503:physiopathology*; D008076:Cholesterol, HDL / Q000097:blood; D004038:Diet, Reducing; D018450:Disease Progression; D005260:Female; D015391:Gastroplasty; D006801:Humans; D007328:Insulin / Q000097:blood; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000000981:diagnostic imaging / Q000503:physiopathology* / Q000628:therapy; D014280:Triglycerides / Q000097:blood; D014463:Ultrasonography; D015431:Weight Loss
D001786:Blood Glucose; D008076:Cholesterol, HDL; D007328:Insulin; D014280:Triglycerides